21. The neurotensin / neuromedin N activators in a number of pathophysiological situations. 22. TIMP-2 functions as both an MMP inhibitor and an activator . 23. However, IRF2 also functions as a transcriptional activator of histone H4. 24. Fibrinogen alpha chain has been shown to interact with Tissue plasminogen activator . 25. This protein is a transcriptional activator which binds to the TLX1 promoter. 26. Polyacrylamide is routinely synthesized in the laboratory with radical activators . 27. This protein functions as both a transcriptional activator and repressor. 28. Here is another use for lysophosphatidylcholine an immune activator . 29. This can be either too much activator being applied or too little. 30. Clotting starts when activator with immobilized TF is immersed into the cuvette.
